Type 2 Diabetes Clinical Trials​

WEL KID STUDY

Purpose: Determine if taking the study drug colesevelam/placebo will lower the type 2 diabetic's HBA1c over a 6 month period of time.

Recruiting:  Individuals ages 10 to 17 years with type 2 diabetes.

TODAY GENETICS STUDY

Purpose: This national study involves collecting biological specimens and family medical history from participants with adolescent onset of type 2 diabetes to explore relationships between possible genetic causes of type 2 diabetes (T2D), as well as obesity, insulin resistance, and cardiovascular complications of insulin resistance.

Recruiting:  Individuals of any age who developed type 2 diabetes mellitus before 18 years of age.

BYETTA STUDY

Purpose:  Determine if type 2 diabetics taking exenatide/placebo will have a change in their HBA1c over a 28 week period of time.  This is a twice daily injectable study drug. 

Recruiting:  Individuals ages 10 to 17 years with type 2 diabetes mellitus.

MK083 STUDY

Purpose: Assess the safety of the addition of sitagliptin, and its effect on hemoglobin A1c in pediatric participants with type 2 diabetes mellitus and inadequate glycemic control.

Recruiting: Individuals ages 10 to 17 years with type 2 diabetes mellitus who have not received treatment with an oral antihyperglycemic agent or insulin for the past 3 months.

Recruitment Contact: 

Marla Hashiguchi, RN

Phone: (858) 966-8940

Email: mhashiguchi@rchsd.org